Dyax, Fovea enter into license agreement
March 1st 2009Dyax Corp. and Fovea Pharmaceuticals have entered into an exclusive license agreement for the development and commercialization of an ocular formulation of DX-88 for the treatment of retinal diseases, the companies announced in a joint statement.
Roche attempts hostile takeover
March 1st 2009Analysts and ophthalmologists are closely watching the drama unfolding between private Swiss drugmaker Roche and the publicly traded, California-based Genentech, maker of ranibizumab (Lucentis), the only FDA-approved treatment for age-related macular degeneration (AMD), and its popular cousin, bevacizumab (Avastin). Roche is attempting a hostile takeover of Genentech.
Implementing an electronic prescribing system
February 27th 2009This is the personal experience of electronic prescribing (e-prescribing) implementation presented by Cindy Maddox, MD, FACS, director of glaucoma services and vice chairwoman at the New England Eye Center, Tufts University School of Medicine, Boston and member of the American Academy of Ophthalmology's health policy committee.
People with astigmatism are unaware of contact lens options, says survey
February 24th 2009A survey conducted by independent research firm, Decision Analyst, and sponsored by Bausch & Lomb, found that four out of 10 consumers incorrectly believe that their astigmatism prevents them from wearing contact lenses.
Mumbai Eye Care Campaign launched to prevent blindness
February 24th 2009Sightsavers International has launched the Mumbai Eye Care Campaign to prevent avoidable blindness and to offer eye care to millions of Mumbai's citizens in underserved areas of the city, such as Dharavi, the setting of the award-winning film, 'Slumdog Millionaire.'
Eye-care position receives new classification in occupational listing
February 18th 2009The Standard Occupational Classification listing encompasses all three levels of JCAHPO certification: certified ophthalmic assistant, certified ophthalmic technician, and certified ophthalmic medical technologist, the organization said.
Pfizer to disclose compensation of U.S. health-care professionals, others
February 18th 2009Pfizer will disclose publicly its compensation of U.S. health-care professionals for consulting, speaking engagements, and clinical trials by early next year on the company’s Web site, according to a prepared statement from the company.
Dyax and Fovea enter into license agreement
February 18th 2009Dyax Corp. and Fovea Pharmaceuticals announced in a joint statement that they have entered into an exclusive license agreement for the development and commercialization of an ocular formulation of DX-88 for the treatment of retinal diseases.
Tear film rebuilding is goal of drop
February 15th 2009A new formulation of lubricant eye drop (Systane Ultra, Alcon Laboratories) contains polymer network and demulcent ingredients that have been proven in multiple studies to provide benefits in patients with dry eye disease, according to one ophthalmologist. The drop, however, reformulates these agents in a system designed to further enhance ocular surface comfort, protection, and symptomatic relief. Initial patient impressions are very positive, he said.
Tear formulations unique in dry eye therapy, management
February 15th 2009Blink GelTears and Blink Tears Preservative-Free (Advanced Medical Optics) are two new over-the-counter products for the treatment of dry eye disease. These products are gaining in popularity with ophthalmologist because of the rapid long-lasting beneficial response they produce in this patient population and the absence of a preservative. The products are also beneficial for patients who have undergone LASIK and cataract surgery and develop subsequent dry eye signs and symptoms postoperatively.
Use technology to improve your contact lens practice
February 15th 2009Contact lens practices are probably feeling the effects of more and more patients simply taking their prescriptions and buying their lenses on the Internet. But, if contact lens fitting is a valuable service that you offer and you want to improve your productivity and profitability, then you might want to make a few changes. Using the Internet to send email updates to patients, ordering supplies online, and giving patients the option to purchase on your Web store will make a big difference in your practice.
Category III codes provide key to new technologies
February 15th 2009Ophthalmologists are well acquainted with the Current Procedural Terminology (CPT), but many ophthalmologists are only familiar with CPT's "Category I" codes. It is important for ophthalmologists to understand code Category III, since many eye-care services have appeared or will appear in this category.
Safilo Group renews Nine West licensing
February 15th 2009Safilo Group announced the renewal of its exclusive licensing agreement with Jones Apparel Group to design, manufacture, and market prescription eyeglass frames for women and children, as well as women's prescription sunglass frames under the Nine West brand.
Lipid emulsion benefits dry eye disease, says doctor
February 15th 2009A compromised lipid layer plays a key role in the development and perpetuation of dry eye disease because it allows increased aqueous evaporation and fails to protect against friction between the blinking lid and the ocular surface. A proprietary brand of emollient eye drops (Soothe XP. Bausch & Lomb) was created to re-establish the tear film lipid layer and restore moisture, and it is an effective choice for providing symptomatic relief in patients with dry eye disease, says one optometrist.
Ophthalmologists' perception of moderate to severe dry eye shown by survey
February 15th 2009Ophthalmologists who responded to questions about treatment of dry eye indicated that there are limitations in the available treatment options, especially for patients with moderate to severe cases of the disease, and that only 5% of ophthalmologists saw existing treatments as effective for the patients with the worst cases.
Eye drops for contact lens wearers are found to be safe
February 15th 2009A clinical trial tested the safety and efficacy of Optive eye drops (Allergan) in contact lens wearers. Participants reported no adverse events and that their lenses were more comfortable to wear; clinical assessment found no adverse events or complications after 4 weeks of treatment.
Dry eye common postLASIK . . . and before
February 15th 2009A review of the world literature shows that about one-third of patients who are undergoing LASIK already suffer from dry eye, and the proportion affected after surgery is similar. In most cases, however, dry eye does not appear to affect postoperative vision and satisfaction outcomes adversely. Identification of patients at risk and pre-treating may reduce the postoperative incidence of dry eye.